Bolt Biotherapeutics rakes in $93.5m Series C
Redwood City, California-based Bolt Biotherapeutics Inc, a biotechnology company, has raised $93.5 million in Series C financing.
1 July 2020•1 min read
Redwood City, California-based Bolt Biotherapeutics Inc, a biotechnology company, has raised $93.5 million in Series C financing.